Stephens Inc. AR Sells 2,588 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• Stephens Inc. AR reduced its stake in UnitedHealth Group by 8.2%, selling 2,588 shares and holding a total of 29,138 shares worth $9,090,000, according to the latest 13F filing.
• UnitedHealth Group's recent earnings report revealed $4.08 earnings per share, missing the consensus estimate of $4.45, with revenues of $111.62 billion, slightly below expectations.
• The company announced a quarterly dividend of $2.21 per share, representing an annualized dividend yield of 2.4%.

Stephens Inc. AR lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 8.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,138 shares of the healthcare conglomerate's stock after selling 2,588 shares during the period. Stephens Inc. AR's holdings in UnitedHealth Group were worth $9,090,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the company. Citizens National Bank Trust Department grew its holdings in shares of UnitedHealth Group by 1.0% in the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock valued at $9,368,000 after acquiring an additional 170 shares in the last quarter. Caitlin John LLC grew its holdings in shares of UnitedHealth Group by 14.8% in the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate's stock valued at $451,000 after acquiring an additional 111 shares in the last quarter. Triumph Capital Management acquired a new stake in UnitedHealth Group in the 2nd quarter valued at about $1,324,000. Wealth Effects LLC lifted its stake in UnitedHealth Group by 14.4% in the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate's stock valued at $1,463,000 after purchasing an additional 591 shares during the last quarter. Finally, Arlington Partners LLC acquired a new stake in UnitedHealth Group in the 2nd quarter valued at about $2,229,000. Institutional investors own 87.86% of the company's stock.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the stock. Cantor Fitzgerald reiterated an "overweight" rating and issued a $440.00 target price on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Sanford C. Bernstein raised their target price on shares of UnitedHealth Group from $379.00 to $433.00 and gave the company an "outperform" rating in a research note on Wednesday, October 8th. Bank of America raised their target price on shares of UnitedHealth Group from $350.00 to $390.00 and gave the company a "neutral" rating in a research note on Wednesday, October 8th. UBS Group restated a "buy" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Finally, Robert W. Baird restated an "underperform" rating and set a $198.00 price objective (down from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Eighteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $385.13.

UnitedHealth Group Stock Up 2.2%

Shares of UNH opened at $364.31 on Tuesday. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The firm's 50 day moving average is $331.62 and its 200-day moving average is $341.12. The stock has a market capitalization of $329.95 billion, a PE ratio of 15.78, a P/E/G ratio of 2.31 and a beta of 0.47. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business's revenue was up 12.9% compared to the same quarter last year. During the same period last year, the business earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group's payout ratio is presently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.